top of page

Featured Publications (5)

All Selected Publications

Prophylactic weekly efanesoctocog alfa versus standard-care factor VIII in people living with severe hemophilia A: a cost-effectiveness analysis

Ito S, Potnis KC, Harvey JP, Sra M, Bewersdorf JP, Bona RD, Krumholz HM, Cuker A, Pandya A, Goshua G.
Annals of Internal Medicine
2025
April
FEATURED
RECOGNITIONS:
View Publication

Gap: First conventional and distributional cost-effectiveness analysis in the care of people living with hemophilia A (Yale-HSPH-Mayo-Penn collaboration). ASH Abstract Achievement Award (S. Ito).

PRACTICAL IMPACT:

Cost-effectiveness of ferritin screening thresholds for iron deficiency in reproductive-age women

Wang D, Sra M, Glaeser-Khan S, Wang DY, Moshashaian-Asl R, Ito S, Cuker A, Goshua G
American Journal of Hematology
2025
April
FEATURED
RECOGNITIONS:
View Publication

Gap: First cost-effectiveness analysis of ferritin screening thresholds in the care of people living with iron deficiency (Yale-Mayo-Vermont-Penn collaboration). 2024 ASH Press Program Selection, 2025 Highlights of ASH, ASH Abstract Achievement Award (D. Wang).

PRACTICAL IMPACT:

Cost-effectiveness of iptacopan for paroxysmal nocturnal hemoglobinuria

Ito S*, Chetlapalli K*, Wang D, Potnis KC, Richmond R, Krumholz H, Lee AI, Cuker A, Goshua G.
Blood
2025
January
FEATURED
RECOGNITIONS:
View Publication

Gap: Proximal complement inhibition is cost-saving for patients with suboptimal response on C5 inhibitor therapy in the United States and can be cost-saving in international jurisdictions (Penn-Yale collaboration).

PRACTICAL IMPACT:

Cost-effectiveness of bevacizumab therapy in the care of patients with hereditary hemorrhagic telangiectasia

Wang D, Ito S, Waldron C, Butt A, Zhang E, Krumholz HM, Al-Samkari H, Goshua G.
Blood Advances
2024
June
FEATURED
RECOGNITIONS:
View Publication

Gap: Decreasing the need for hospital, emergency, and procedural care with the use of bevacizumab (vs no bevacizumab) improves quality-adjusted life expectancy and saves costs in the care of people living with HHT (MGH-Yale collaboration). ASH Abstract Achievement Award, Best of ASH (HTRS) (D. Wang)

PRACTICAL IMPACT:

Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource

Ito S, Pandya A, Hauser RG, Krishnamurti L, Stites E, Tormey C, Krumholz HM, Hendrickson JE, Goshua G
American Journal of Hematology
2024
April
FEATURED
RECOGNITIONS:
View Publication

Gap: Supporting the mission of the 501(c)(3) Alloantibody Exchange www.alloantibody.org. 2022 ASH Press Program Selection.

PRACTICAL IMPACT:
Load More
Abstract Futuristic Background

Publications

bottom of page